Results 71 to 80 of about 119,738 (212)

Esophageal involvement of pemphigus vulgaris associated with upper gastrointestinal bleeding [PDF]

open access: yes, 2014
Esophageal involvement of pemphigus vulgaris is rare, and when present, the most common presenting symptoms reported in the medical literature are odynophagia and dysphagia.
김현주   +6 more
core   +1 more source

Mapping the Altered Landscape of TCR Repertoire in Autoimmune Diseases

open access: yesImmunological Reviews, Volume 342, Issue 1, September 2026.
ABSTRACT Autoimmune diseases arise from the breakdown of immune tolerance through complex interactions between genetic predisposition, environmental exposures, and adaptive immune responses. High‐throughput T‐cell receptor (TCR) repertoire sequencing has transformed our ability to characterize these responses, providing unprecedented insights into ...
Celine Albalaa   +3 more
wiley   +1 more source

Pemphigus Vulgaris and Pemphigus Foliaceus Antibodies are Pathogenic in Plasminogen Activator Knockout Mice [PDF]

open access: yes, 1999
Previous studies have suggested that urokinase plasminogen activator is required for blister formation in pemphigus vulgaris and pemphigus foliaceus.
Stanley, John R.   +2 more
core   +1 more source

Long‐Term Safety and Efficacy of Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: ADHERE/ADHERE+ Trial Interim Analysis

open access: yesJournal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.
ABSTRACT Background and Aims In ADHERE, subcutaneous efgartigimod PH20 (1000 mg once weekly) was effective and well tolerated in participants with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). ADHERE+ is an open‐label extension of ADHERE assessing long‐term safety and efficacy. Methods Eligible participants from ADHERE run‐in period
Jeffrey A. Allen   +8 more
wiley   +1 more source

Management of pemphigus vulgaris: challenges and solutions

open access: yes, 2015
Stamatis Gregoriou, Ourania Efthymiou, Christina Stefanaki, Dimitris Rigopoulos 2nd Department of Dermatology and Venereology, University of Athens Medical School, Attikon Hospital, Athens, Greece Abstract: The main objective in the treatment of ...
Gregoriou S   +3 more
core  

Oral pemphigus vulgaris in a pediatric patient

open access: yesJournal of Indian Society of Pedodontics and Preventive Dentistry, 2010
Pemphigus vulgaris is a chronic autoimmune mucocutaneous disease that initially manifests in the form of intraoral lesions, which spread to other mucous membranes and the skin. The etiology of pemphigus vulgaris is still unknown, although the disease has
Anand R, Jaiswal J, Samadi F
doaj  

Testing optimal defense theory: Root resistance selection in chicory (Cichorium intybus) reduces foliar defense and alters aphid performance and feeding behavior

open access: yesPest Management Science, Volume 82, Issue 8, Page 7951-7960, August 2026.
Root‐focused resistance in chicory reduces defenses in leaves, impairing root aphids but enhancing foliar aphid performance. Selecting root resistance can create unintended trade‐offs across plant organs. Abstract BACKGROUND Plants are constantly exposed to a wide range of herbivores at both aboveground (AG) and belowground (BG) levels, involving ...
Thomas Cochenille   +5 more
wiley   +1 more source

Emerging treatment options for the management of pemphigus vulgaris

open access: yes, 2018
Khalaf Kridin Department of Dermatology, Rambam Health Care Campus, Haifa, Israel Abstract: Pemphigus vulgaris (PV) is a life-threatening disease belonging to the pemphigus group of autoimmune intra-epidermal bullous diseases of the skin and mucosae ...
Kridin K
core  

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris

open access: yesActa Dermato-Venereologica, 2020
Rituximab targets the B-lymphocyte antigen CD20, providing pemphigus vulgaris patients with long-term remissions. However, the effects of repeated courses have not yet been established.
Sharon Baum   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy